Abstract
Netherton syndrome (NS) is an inherited ichthyosis without targeted therapies, and current treatment remains largely symptomatic. Herein, we report the case of a 6-year-old patient with NS successfully managed with dupilumab for 3 years. The literature regarding dupilumab treatment in this patient population is summarized, and the potential role of dupilumab in altering the pathogenesis of NS is discussed.

This publication has 23 references indexed in Scilit: